BROOKE HARNESS: Open Payments
NPI 1124805080 · PACIFIC, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$231 in 12 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $315 · 2025 $231
Food & beverage: $231
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $69 |
| ABBVIE INC. | 3 | $51 |
| Otsuka America Pharmaceutical, Inc. | 1 | $31 |
| Novo Nordisk Inc | 1 | $20 |
| PFIZER INC. | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: VRAYLAR, MOUNJARO, REXULTI, Ozempic, ELIQUIS, TRELEGY ELLIPTA, XIFAXAN, FARXIGA.
Industry payments across MO — which companies pay providers there.
